Letter to Editor Regarding Narula et al, IBD 2017, Budenoside Use Is a Key Quality Marker in the Management of IBD

Inflamm Bowel Dis. 2017 Aug;23(8):E41. doi: 10.1097/MIB.0000000000001184.

Authors

Richard C G Pollok¹, Sonia Saxena, Chris Alexakis, Vivek Chhaya

Affiliation

¹ *Department Gastroenterology, St George's University of London, St George's University Hospitals NHS Foundation Trust, London, United Kingdom †Department of Primary Care and Public Health, Charing Cross Campus, Imperial College London, London, United Kingdom.

PMID: 28644186
DOI: 10.1097/MIB.0000000000001184

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers*
Inflammatory Bowel Diseases*
Quality Improvement

Substances

Biomarkers

Grants and funding

CDF-2011-04-048/DH_/Department of Health/United Kingdom